MagnaMedics Diagnostics BV moved on December 2008 from Maastricht Biopartner Centre to the new Chemelot Research & Business Campus in Geleen. “We have passed our start-up phase,” says MagnaMedics’ CSO-CEO Paul Borm. “At Chemelot we can use the available know-how and facilities on new materials, to further extend our production and markets. Download here the article in Link magazine (german).

UPDATE July 1st 2009: Click here to read the Dutch article in 'Limburg Onderneemt' about the inovation at Chemelot.